Skip to content

WallFlex Biliary M00570340Recalls & reported problems

Boston Scientific Corporation · Stent System RMV · Class 2 · Implant

Adverse event reports
3
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08714729953159), received between Apr 20, 2020 and Jul 25, 2025 — classified as 3 injuries.

The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 1 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Detachment of Device or Device Component1
  • Difficult to Remove1
  • Migration1
  • Use of Device Problem1

Patient problems

  • Anemia1
  • Dehydration1
  • Erosion1
  • Hemorrhage/Blood Loss/Bleeding1
  • Jaundice1
  • No Code Available1
  • No Consequences Or Impact To Patient1
  • Pressure Sore/Ulcer1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 25, 2025Use of Device Problem; Use of Device Problem

    IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A WALLFLEX BILIARY FULLY COVERED STENT RMV WAS IMPLANTED IN THE COMMON BILE DUCT TO TREAT CHOLEDOCHOLITHIASIS AND FOR PROPHYLAXIS BLEEDING TREATMENT DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PROCEDURE (ERCP) PERFORMED ON (B)(6) 2023. DURING THE PROCEDURE, THE WALLFLEX BILIARY STENT WAS SUCCESSFULLY DEPLOYED. HOWEVER, POST STENT PLACEMENT, THE PATIENT STARTED BLEEDING. ON (B)(6) 2025, THE PATIENT UNDERWENT A REPEAT ERCP, AND THE PHYSICIAN FOUND THE BLEEDING ULCER INSIDE THE DISTAL DUCT WALL. BIPOLAR CAUTERY WAS APPLIED, FOLLOWED BY THE PLACEMENT OF A RESOLUTION CLIP AND THE ADMINISTRATION OF HEMOSPRAY. IN THE PHYSICIAN'S ASSESSMENT, THE PRESSURE ULCER CONTRIBUTED TO THE BLEEDING, WHICH WAS CAUSED BY THE WALLFLEX STENT. THE STENT REMAINS IMPLANTED, AND THE PATIENT IS CURRENTLY ADMITTED AND UNDER OBSERVATION SINCE THE HEMOGLOBIN STARTED TO DROP. IN THE PHYSICIAN'S ASSESSMENT, THE HEMOGLOBIN LEVEL OF THE PATIENT STABILIZED AFTER THE PRESSURE ULCER WAS TREATED. ON ON (B)(6) 2025, THE PATIENT WAS DISCHARGED FROM THE HOSPITAL. NOTE: ACCORDING TO THE COMPLAINANT, THE WALLFLEX BILIARY RX FULLY COVERED RMV STENT WAS IMPLANT

    Patient problems: Anemia; Erosion; Hemorrhage/Blood Loss/Bleeding; Pressure Sore/Ulcer

    MAUDE report 22613829 ↗
  • InjuryApr 23, 2020Difficult to Remove; Detachment of Device or Device Component; Difficult to Remove; Detachment of Device or Device Component

    IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION ON APRIL 03, 2020 THAT A WALLFLEX BILIARY RX FULLY COVERED RMV STENT WAS IMPLANTED TO TREAT A BILIARY STRICTURE DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) WITH STENT PLACEMENT PROCEDURE PERFORMED ON (B)(6) 2020. REPORTEDLY, THE PATIENT'S ANATOMY WAS NOT TORTUOUS AND WAS NOT DILATED PRIOR TO STENT PLACEMENT. ACCORDING TO THE COMPLAINANT, DURING THE PROCEDURE, THE STENT WAS ABLE TO BE DEPLOYED; HOWEVER, DURING REMOVAL OF THE DELIVERY SYSTEM, THE TIP OF THE DEPLOYMENT CATHETER GOT CAUGHT ON THE STENT AND BROKE OFF. THE BROKEN PARTS OF THE DELIVERY SYSTEM WERE REMOVED FROM THE PATIENT USING SNARE. REPORTEDLY, THE STENT REMAINS IMPLANTED AND THE PROCEDURE WAS COMPLETED WITH THIS DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. THE PATIENT'S CONDITION AT THE CONCLUSION OF THE PROCEDURE WAS REPORTED TO BE GOOD.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 9992862 ↗
  • InjuryApr 20, 2020Migration; Migration

    IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION ON (B)(6), 2020 THAT A WALLFLEX BILIARY RX FULLY COVERED RMV STENT WAS IMPLANTED IN THE COMMON BILE DUCT DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) WITH STENT PLACEMENT PROCEDURE PERFORMED ON (B)(6) 2019. ACCORDING TO THE COMPLAINANT, ON (B)(6), 2020, THE PATIENT RETURNED TO THE HOSPITAL AND THE STENT WAS NOTED TO HAVE MIGRATED OUT. A PLASTIC STENT WAS IMPLANTED TO ENSURE DRAINAGE. ON (B)(6), 2020, ANOTHER WALLFLEX BILIARY STENT WAS IMPLANTED. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. THE PATIENT'S CONDITION AT THE CONCLUSION OF THE PROCEDURE WAS REPORTED TO BE FINE. ***ADDITIONAL INFORMATION RECEIVED ON (B)(6), 2020*** IT WAS REPORTED THAT THE WALLFLEX BILIARY RX FULLY COVERED RMV STENT WAS INDICATED TO TREAT A MALIGNANT STRICTURE IN THE DISTAL BILE DUCT. ACCORDING TO THE COMPLAINANT, THE PATIENT PRESENTED WITH DEHYDRATION AND JAUNDICE. A COMPUTERIZED TOMOGRAPHY (CT) SCAN WAS PERFORMED AND CONFIRMED THAT THE STENT HAD COMPLETELY MIGRATED AND PASSED OUT NATURALLY FROM THE PATIENT. PER THE PHYSICIAN, THE STRICTURE LIKELY SHRANK DUE TO CHEMOTHERAPY.

    Patient problems: Dehydration; Jaundice; No Code Available

    MAUDE report 9977433 ↗

Other Biliary stent system for benign strictures devices

All Biliary stent system for benign strictures devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.